Search

Memorial Sloan Kettering Cancer Center (MSK) today announced an innovative set of initiatives to support underserved communities in New York City who lack access to cancer screening and early detection.

… Monday, May 6, 2024 Memorial Sloan Kettering Cancer Center (MSK) today announced an innovative set of initiatives to support underserved communities in New York City who lack access to cancer screening and early detection. With critical support from longtime MSK Board Member, real estate developer, and

Meet a former NYPD officer who is battling a vicious enemy - ovarian cancer - with support from her new wife.

… Friday, June 24, 2016 Summary Vilma Rosario had just been cleared of non-Hodgkin’s lymphoma , a blood cancer, when she was diagnosed with early-stage ovarian cancer . She had already postponed her wedding once before and wasn’t going to let the disease steal her joy a second time. With support from their

Learn how engineering immune cells to metabolize fructose could supercharge them to fight cancer.

… Thursday, February 27, 2025 Immune cells might be reprogrammed to use the body’s fructose — a naturally occurring sugar — as an energy source that supercharges them to fight cancer, researchers at Memorial Sloan Kettering Cancer Center (MSK) have found. The engineered immune cells showed strong anti-tumor

A study that shows lung cancer risk varies widely among smokers may help individuals and their doctors decide if voluntary screening is appropriate for them.

… Wednesday, March 19, 2003 Smoking, the number one cause of preventable death in the United States, causes 130,000 lung cancer deaths each year. Many smokers are now considering screening with low-dose helical computed tomography (CT) scans in the hope of diagnosing the disease early. A new study that

MSK award recognizes promising investigators for their efforts in advancing cancer research.

… Tuesday, November 12, 2019 Nathanael Gray, Joshua Mendell, and Christopher Vakoc (From left) Nathanael Gray, Joshua Mendell, and Christopher Vakoc are the three recipients of the 2019 Paul Marks Prize for Cancer Research. Memorial Sloan Kettering (MSK) has named three investigators as the recipients

A collaborative effort among cancer experts from Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College has yielded an interesting association: Obesity prior to diagnosis is associated with a five-fold increase in the risk of death from early-stage squamous cell carcinoma of the tongue.

… Tuesday, February 4, 2014 Cancer experts from Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College are working side by side to unravel the mysterious link between obesity and cancer. Most recently, their collaborative effort has yielded an interesting association: Obesity prior to

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Friday, February 19, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Three MSK Experts Named to New Class of American Academy of Microbiology Fellows Esther Babady, Kenneth Marians, and Tobias Hohl Esther Babady, PhD, D(ABMM), FIDSA , Clinical Microbiology

A new study by researchers at Memorial Sloan Kettering Cancer Center reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse.

… Thursday, July 2, 2009 A new study by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse. The study will be published

A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels - a marker for tumor growth - in men with advanced prostate cancer for whom traditional treatment options have failed.

… Thursday, April 9, 2009 A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels - a marker for tumor growth - in men with advanced prostate cancer for whom traditional treatment options have failed. The study, led by researchers at Memorial Sloan Kettering

Memorial Sloan Kettering and the City College of New York (CCNY) were recently awarded a $4 million grant from the National Institutes of Health to study the use of machine learning for early breast cancer detection in high-risk women.

… Monday, February 1, 2021 Memorial Sloan Kettering Cancer Center and the City College of New York (CCNY) were recently awarded a $4 million grant from the National Institutes of Health to study the use of machine learning for early breast cancer detection in high-risk women . The estimated five-year project